O Hyperglycemia and Diabetes Mellitus: Monitor patients for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. These metabolic changes include hyperglycemia, dyslipidemia, and weight gain. Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/ cerebrovascular risk.Tardive dyskinesia: Consider discontinuing risperidone if clinically indicated.Neuroleptic Malignant Syndrome: Manage with immediate discontinuation of risperidone and close monitoring.Risperidone is not approved for use in patients with dementia-related psychosis ( 5.2) Cerebrovascular events, including stroke, in elderly patients with dementia- related psychosis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |